Link Between Chronic Bacterial Inflammation and Alzheimer DiseaseSoothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology.5-HT5 ReceptorsRole of acetylcholinesterase inhibitors in the metabolism of amyloid precursor proteinAcamprosate: a prototypic neuromodulator in the treatment of alcohol dependenceNeurovascular signals suggest a propagation mechanism for endogenous stem cell activation along blood vesselsHeteromerization of G protein-coupled receptors: relevance to neurological disorders and neurotherapeutics.Biphasic mechanisms of neurovascular unit injury and protection in CNS diseasesN-3 (omega-3) polyunsaturated Fatty acids in the pathophysiology and treatment of depression: pre-clinical evidenceImmunotherapy for drug abuseThe role of the catechol-O-methyltransferase (COMT) gene in personality and related psychopathological disordersThe battle of the sexes for stroke therapy: female- versus male-derived stem cellsInnate immunity in Alzheimer's disease: a complex affairPathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophyNitric Oxide-GAPDH Transcriptional Signaling Mediates Behavioral Actions of CocaineAdhesion molecules in CNS disorders: biomarker and therapeutic targetsCrystal structure and interaction of phycocyanin with β-secretase: A putative therapy for Alzheimer's diseaseGlutamate Transporter GLT-1 as a Therapeutic Target for Substance Use DisordersMetabotropic Glutamate Receptor 7 (mGluR7) as a Target for the Treatment of Psychostimulant DependenceOld and new drug targets in diabetic retinopathy: from biochemical changes to inflammation and neurodegenerationAnxioselective compounds acting at the GABA(A) receptor benzodiazepine binding siteGalanin: a biologically active peptideThe metabotropic glutamate receptors: structure, activation mechanism and pharmacologyFatty acid amide hydrolase inhibitors--progress and potential5-ht6 receptorsEndocannabinoids in appetite control and the treatment of obesityGalanin/GALP receptors and CNS homeostatic processesFetzima (levomilnacipran), a drug for major depressive disorder as a dual inhibitor for human serotonin transporters and beta-site amyloid precursor protein cleaving enzyme-1The NR2B subtype of NMDA receptor: a potential target for the treatment of alcohol dependenceMechanisms of mononuclear phagocyte recruitment in Alzheimer's diseaseTargeting kynurenine 3-monooxygenase (KMO): implications for therapy in Huntington's diseaseThe brain galanin receptors: targets for novel antidepressant drugsRole of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuseThe proNGF-p75NTR-sortilin signalling complex as new target for the therapeutic treatment of Parkinson's diseaseProtein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitusBiosynthetic pathways of bioactive N-acylethanolamines in brainmiR-15b suppression of Bcl-2 contributes to cerebral ischemic injury and is reversed by sevoflurane preconditioningA synopsis on the role of tyrosine hydroxylase in Parkinson's disease5-HT2 receptors.Activity-Dependent Neurorehabilitation Beyond Physical Trainings: "Mental Exercise" Through Mirror Neuron Activation.
P1433
Q22241319-9B997746-1DC3-4085-8EAF-27259F6D90C3Q22241320-3BFA2D05-1AF5-4DA3-B7A5-D6DB662A4CC4Q22241326-81497067-7254-4426-8C4F-1689364657B9Q24302890-92A6027E-769D-41DD-B12B-54F3DBC9ECF5Q24595863-6CE9894D-BDD9-44B6-AC9D-E184ACEF3313Q24617068-F588B001-E202-4903-B0EF-933BEB67243CQ24630645-F6FF4228-A2FA-4433-A529-A8C75C79D9BCQ26827146-E43DA27A-211A-4F24-A3DD-A6373BE440B6Q26849307-F501FC42-B77A-4C3E-B85C-6F91ED4EE420Q26853633-65F99541-7C7E-4CE2-8D2D-FB6130EB616FQ26863407-329DBFBA-306A-4B5D-929D-7AEEE11A87B5Q26996178-B22A386D-1779-429C-AB89-F0510CCBDC35Q27006944-2B1204ED-DC75-44B1-BB22-0740053346F8Q27007098-409400C5-D9BB-47A8-8A68-5F4AF3B1A2A1Q27009552-11FAC602-58CD-4AF6-9D5E-05FF7988A333Q27015967-2EA483F1-DC31-4BC2-BCFD-6BE414B4978FQ27689361-E276622A-3F3F-4B03-A302-A76D21BF5D63Q28081726-A2643B19-CDE3-420C-9532-CD8EB2A0D336Q28084494-6A95FC48-7F08-4496-9689-F51C579368A2Q28187496-D0D589B7-51B8-4104-9925-5D8F8D10EBB2Q28188111-E44E28B6-630C-47A0-A7AE-3C72752BD92AQ28206962-F53F4801-7DB0-4CF3-8509-674BEF14C7FBQ28206978-4787021A-EFEF-40D5-A8B3-CF2709DF0C9AQ28239217-7258ED21-4F7F-442F-A1AC-AB51224B0C13Q28245286-E6584CA9-E6C9-41EC-BDCA-3C086429C683Q28247257-D2485815-9DC5-4308-B774-C2CC46EDE417Q28247269-B5FFDBB2-CE9F-4A31-A780-387C627CE4AEQ28250342-3D6F4479-D05B-46DD-9E24-04209146DFD5Q28265181-F47AA530-EC38-43EE-B7CE-0EFB0216913EQ28275105-242FE159-D14B-4ACA-AA9C-901171C6A8A8Q28295489-056794CE-72E0-4883-9F69-F5740CDCA2E2Q28303033-385A12A8-3F0E-4098-812F-7BB1D1449B44Q28306056-2C7494C9-576C-45C3-A297-DE74A58F282EQ28306065-CF9B7EAC-D76E-4A85-89D9-2E3B2A821798Q28397425-396D31B8-9BC9-4ADF-B800-7B1D34FF0599Q28609485-AEAF2C72-5C40-46D8-937D-035C13480091Q28657605-B8A96BCE-BCA8-45DF-AA99-EFAF3D09B0FCQ28830946-4B9736B1-64BD-4E68-A503-5D085D97BBB2Q30339012-C72CEBA9-967F-439E-9C64-3DB0A6EB887AQ30381230-5CD8E747-BB26-489D-A570-97700EB3CD4D
P1433
description
journal
@en
publikation
@de
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Bentham Science Publishers
@nl
مجلة
@ar
वैज्ञानिक पत्रिका
@hi
name
CNS & Neurological Disorders – Drug Targets
@de
CNS and Neurological Disorders
@da
CNS and Neurological Disorders
@en
CNS and Neurological Disorders
@es
CNS and Neurological Disorders
@fi
CNS and Neurological Disorders
@fr
CNS and Neurological Disorders
@it
CNS and Neurological Disorders
@nb
CNS and Neurological Disorders
@nl
CNS and Neurological Disorders
@nn
type
label
CNS & Neurological Disorders – Drug Targets
@de
CNS and Neurological Disorders
@da
CNS and Neurological Disorders
@en
CNS and Neurological Disorders
@es
CNS and Neurological Disorders
@fi
CNS and Neurological Disorders
@fr
CNS and Neurological Disorders
@it
CNS and Neurological Disorders
@nb
CNS and Neurological Disorders
@nl
CNS and Neurological Disorders
@nn
altLabel
C N S & Neurological Disorders - Drug Targets
@en
prefLabel
CNS & Neurological Disorders – Drug Targets
@de
CNS and Neurological Disorders
@da
CNS and Neurological Disorders
@en
CNS and Neurological Disorders
@es
CNS and Neurological Disorders
@fi
CNS and Neurological Disorders
@fr
CNS and Neurological Disorders
@it
CNS and Neurological Disorders
@nb
CNS and Neurological Disorders
@nl
CNS and Neurological Disorders
@nn
P236
P1055
P1058
P1156
P1250
P1277
P1476
CNS & Neurological Disorders – Drug Targets
@und
P236
P407
P571
2006-01-01T00:00:00Z